Martin D. Fleming

2.9k total citations
35 papers, 630 citations indexed

About

Martin D. Fleming is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Martin D. Fleming has authored 35 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 8 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Martin D. Fleming's work include Cutaneous Melanoma Detection and Management (8 papers), CAR-T cell therapy research (6 papers) and Melanoma and MAPK Pathways (5 papers). Martin D. Fleming is often cited by papers focused on Cutaneous Melanoma Detection and Management (8 papers), CAR-T cell therapy research (6 papers) and Melanoma and MAPK Pathways (5 papers). Martin D. Fleming collaborates with scholars based in United States, United Kingdom and Canada. Martin D. Fleming's co-authors include John B. Hamner, Irvin D. Fleming, Rex A. Amonette, Jim Y. Wan, Thomas Barrett, R. Kitching, Carlos H. Romero, D. N. Black, Alberto S. Pappo and Robert W. Cook and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Annals of Surgery.

In The Last Decade

Martin D. Fleming

31 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin D. Fleming United States 13 341 187 130 115 86 35 630
K. Syrj�nen Finland 14 269 0.8× 383 2.0× 165 1.3× 98 0.9× 46 0.5× 20 705
Luciano B. Lemos United States 15 106 0.3× 277 1.5× 86 0.7× 107 0.9× 67 0.8× 32 662
Steven P. Tjong‐A‐Hung Netherlands 13 133 0.4× 432 2.3× 228 1.8× 134 1.2× 29 0.3× 17 642
R. J. Kurman United States 12 154 0.5× 426 2.3× 200 1.5× 140 1.2× 19 0.2× 16 822
Talaat S. Tadros United States 12 108 0.3× 217 1.2× 128 1.0× 63 0.5× 30 0.3× 28 476
K Nasiell Sweden 11 187 0.5× 613 3.3× 232 1.8× 109 0.9× 28 0.3× 19 869
Usha Kim India 16 84 0.2× 57 0.3× 142 1.1× 156 1.4× 32 0.4× 65 696
Magdolna Bollmann Germany 16 156 0.5× 408 2.2× 267 2.1× 126 1.1× 24 0.3× 30 639
Christian J. Haas Germany 13 77 0.2× 138 0.7× 119 0.9× 116 1.0× 24 0.3× 24 573
Isabelle Fayt Belgium 18 217 0.6× 212 1.1× 253 1.9× 149 1.3× 50 0.6× 50 1.3k

Countries citing papers authored by Martin D. Fleming

Since Specialization
Citations

This map shows the geographic impact of Martin D. Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin D. Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin D. Fleming more than expected).

Fields of papers citing papers by Martin D. Fleming

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin D. Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin D. Fleming. The network helps show where Martin D. Fleming may publish in the future.

Co-authorship network of co-authors of Martin D. Fleming

This figure shows the co-authorship network connecting the top 25 collaborators of Martin D. Fleming. A scholar is included among the top collaborators of Martin D. Fleming based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin D. Fleming. Martin D. Fleming is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fleming, Martin D., et al.. (2024). Beyond AI Exposure: Which Tasks are Cost-Effective to Automate with Computer Vision?. SSRN Electronic Journal. 11 indexed citations
2.
Thompson, Neil, et al.. (2024). A Model for Estimating the Economic Costs of Computer Vision Systems That Use Deep Learning. Proceedings of the AAAI Conference on Artificial Intelligence. 38(21). 23012–23018. 2 indexed citations
3.
Fleming, Martin D., et al.. (2023). Early-stage breast cancer treatment disparities in the Midsouth: Has anything changed?. The American Journal of Surgery. 226(4). 447–454.
4.
Dickson, Paxton V., Evan S. Glazer, David Shibata, et al.. (2022). Visceral angiosarcoma: A nationwide analysis of treatment factors and outcomes. Journal of Surgical Oncology. 125(8). 1231–1237. 3 indexed citations
5.
Glazer, Evan S., et al.. (2021). Impact of adjuvant therapies following surgery for anal melanoma. The American Journal of Surgery. 223(6). 1132–1143. 6 indexed citations
6.
Gandhi, Jatin, et al.. (2020). Impact of margin status on survival after radical nephrectomy for renal cell carcinoma. Journal of Surgical Oncology. 123(2). 687–692. 2 indexed citations
7.
Stiles, Zachary E., Paxton V. Dickson, Evan S. Glazer, et al.. (2017). Impact of body mass index on the short-term outcomes of resected gastrointestinal stromal tumors. Journal of Surgical Research. 217. 123–130. 12 indexed citations
8.
Giri, Smith, George Yaghmour, Jeremiah L. Deneve, et al.. (2017). Addition of Rituximab to Chemotherapy Reduced the Rate of Surgery for Gastric-DLBCL Without Increasing Early Mortality. Anticancer Research. 37(2). 813–818. 5 indexed citations
9.
Dong, Lei, Jim Y. Wan, Jeremiah L. Deneve, et al.. (2017). Better Late than Never? Adherence to Adjuvant Therapy Guidelines for Stage III Colon Cancer in an Underserved Region. Journal of Gastrointestinal Surgery. 22(1). 138–145. 4 indexed citations
10.
Hamner, John B. & Martin D. Fleming. (2007). Lymphedema Therapy Reduces the Volume of Edema and Pain in Patients with Breast Cancer. Annals of Surgical Oncology. 14(6). 1904–8. 80 indexed citations
11.
Navid, Fariba, Wayne L. Furman, Martin D. Fleming, et al.. (2005). The feasibility of adjuvant interferon α‐2b in children with high‐risk melanoma. Cancer. 103(4). 780–787. 46 indexed citations
12.
Fleming, Martin D., et al.. (2000). Sentinel lymph node biopsy for melanoma in young children. Journal of Pediatric Surgery. 35(6). 965–966. 17 indexed citations
13.
Bressem, Marie‐Françoise Van, Koen Van Waerebeek, Martin D. Fleming, & Thomas Barrett. (1998). Serological evidence of morbillivirus infection in small cetaceans from the Southeast Pacific. Veterinary Microbiology. 59(2-3). 89–98. 25 indexed citations
14.
Wan, Jim Y., et al.. (1997). Colon Cancer with Metastasis to the Ovary at Time of Initial Diagnosis. Gynecologic Oncology. 66(3). 368–371. 71 indexed citations
15.
Bear, Harry D., Margaret M. Grimes, Martin D. Fleming, et al.. (1996). Long-Term Results of Breast Conservation Therapy for Breast Cancer. Annals of Surgery. 223(6). 709–717. 35 indexed citations
16.
Fleming, Irvin D., et al.. (1995). Principles of management of basal and squamous cell carcinoma of the skin. Cancer. 75(S2). 699–704. 80 indexed citations
17.
Fleming, Martin D., et al.. (1995). Adoptive Transfer of Bryostatin-Activated Tumor-Sensitized Lymphocytes Prevents or Destroys Tumor Metastases Without Expansion In Vitro. Journal of Immunotherapy. 18(3). 147–155. 11 indexed citations
18.
Fleming, Irvin D. & Martin D. Fleming. (1994). Breast cancer in elderly women. Cancer. 74(S7). 2160–2164. 17 indexed citations
20.
Tuttle, Todd M., et al.. (1994). Ability of low-dose cyclophosphamide to overcome metastasis-induced immunosuppression. Annals of Surgical Oncology. 1(1). 53–58. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026